3D Global Biotech Inc. (TPEX:6808)

3D Global Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,760	5,131	1,088	1,498	2,143	2,645
Market Cap Growth	20.86%	371.49%	-27.35%	-30.09%	-18.98%	-
Enterprise Value	3,076	4,797	915	1,295	1,901	2,368
Last Close Price	48.30	66.14	19.00	26.32	38.77	47.86
PE Ratio	28.28	55.95	-	-	-	-
PS Ratio	11.57	19.31	52.74	109.79	193.46	199.42
PB Ratio	4.15	5.67	3.71	4.40	5.50	5.89
P/TBV Ratio	4.56	6.28	5.69	6.70	9.03	9.44
P/FCF Ratio	42.20	344.12	-	-	-	-
P/OCF Ratio	38.58	261.08	-	-	-	-
EV/Sales Ratio	9.47	18.05	44.33	94.89	171.68	178.57
EV/EBITDA Ratio	20.19	45.85	-	-	-	-
EV/EBIT Ratio	24.23	54.20	-	-	-	-
EV/FCF Ratio	34.52	321.70	-	-	-	-
Debt / Equity Ratio	0.10	0.09	0.04	0.05	0.06	0.05
Debt / EBITDA Ratio	0.57	0.77	-	-	-	-
Debt / FCF Ratio	0.97	5.69	-	-	-	-
Asset Turnover	0.41	0.39	0.06	0.03	0.02	0.03
Inventory Turnover	2.47	17.14	4.41	5.14	9.16	7.15
Quick Ratio	10.69	15.75	6.34	10.41	15.71	23.46
Current Ratio	11.34	15.93	6.63	10.71	16.04	23.64
Return on Equity (ROE)	19.65%	15.31%	-18.28%	-18.37%	-14.24%	-10.22%
Return on Assets (ROA)	10.08%	8.12%	-11.30%	-10.41%	-8.57%	-6.36%
Return on Capital (ROIC)	10.90%	8.55%	-11.88%	-10.78%	-8.83%	-6.54%
Return on Capital Employed (ROCE)	12.90%	9.00%	-21.10%	-18.90%	-15.20%	-10.70%
Earnings Yield	3.56%	1.79%	-5.33%	-4.48%	-2.79%	-1.81%
FCF Yield	2.37%	0.29%	-2.98%	-2.36%	-1.81%	-0.88%
Dividend Yield	1.10%	0.80%	-	-	-	-
Buyback Yield / Dilution	-31.23%	-26.08%	-2.32%	-1.69%	-0.77%	-6.02%
Total Shareholder Return	-30.12%	-25.27%	-2.32%	-1.69%	-0.77%	-6.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.